Editorial: Diabetes and cardiovascular disease: new therapeutic interventions

Maria Consiglia Trotta; Michele D'Amico; Ludwig T Weckbach; Anca Hermenean; Bartolo Ferraro

doi:10.3389/fphar.2024.1472636

Editorial: Diabetes and cardiovascular disease: new therapeutic interventions

Front Pharmacol. 2024 Aug 12:15:1472636. doi: 10.3389/fphar.2024.1472636. eCollection 2024.

Authors

Maria Consiglia Trotta¹, Michele D'Amico¹, Ludwig T Weckbach^{2

3

4

5}, Anca Hermenean^{6

7}, Bartolo Ferraro^{3

4}

Affiliations

¹ Department of Experimental Medicine, University of Campania "Luigi Vanvitelli", Naples, Italy.
² German Center for Cardiovascular Research (DZHK), Partner Site Munich Heart Alliance, Munich, Germany.
³ Institute of Cardiovascular Physiology and Pathophysiology, Biomedical Center, Ludwig- Maximilian-University Munich, Munich, Germany.
⁴ Medizinische Klinik und Poliklinik I, Klinikum der Universität, Ludwig-Maximilians-University Munich, Munich, Germany.
⁵ Walter Brendel Centre of Experimental Medicine, Ludwig-Maximilians-University Munich, University Hospital, Munich, Germany.
⁶ Faculty of Medicine, Vasile Goldis Western University of Arad, Arad, Romania.
⁷ "Aurel Ardelean" Institute of Life Sciences, Vasile Goldis Western University of Arad, Arad, Romania.

No abstract available

Keywords: cardiovascular diseases; diabetes; drug discovery; experimental pharmacology; inflammation; neuro-cardio-renal system; therapies.

Publication types

Editorial

Grants and funding

The author(s) declare that financial support was received for the research, authorship, and/or publication of this article. AH is supported by the Romanian Ministry of Research, Innovation, and Digitization, CNCS/CCCDI-UEFISCDI, project number PN-III-P4-ID-PCE-2020-1772, within PNCDI III. LW is supported by the Else Kröner Fresenius Stiftung (Project 2023_EKEA.11).